NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced today that it has received approval for the dual listing of its common shares on the Canadian Securities Exchange (CSE).
Columbia Care’s common shares will begin trading in Canadian Dollars on the CSE on March 31, 2020 under the symbol CCHW. In addition, the Company’s common shares will continue to trade in Canadian Dollars on its primary, senior listing exchange, the NEO Exchange (“NEO”), as well as the OTCQX® Best Market (“OTC”) in US Dollars and the Frankfurt Stock Exchange in Euros.
“Investors asked us to consider listing on the CSE to provide additional exposure,” said CEO Nicholas Vita. “After a thoughtful review process, we determined that retaining the status of being listed on a senior exchange like the NEO could be complemented by adding the access and visibility of the CSE, which is the exchange most commonly used by US cannabis companies. Optimizing CCHW’s long-term trading dynamics has been a priority, so we decided to get the best of both worlds and establish a dual listing with the NEO and the CSE. We are delighted and grateful for the support of both exchanges and thank them for their creativity. The next step towards further improving our technical trading dynamics will come once we finish the DTC eligibility process in the coming weeks.”
Richard Carleton, CEO of the CSE added: “The CSE is pleased to welcome Columbia Care to the exchange. With this listing, Columbia Care joins their peer group of leading US cannabis companies that have chosen to enhance their capital formation and secondary market liquidity activities on the CSE. We look forward to working with the Columbia Care team to expand their range of potential investors.”
Caution regarding Forward-Looking statements
This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws, which reflect the Company’s current expectations regarding future events. The Company has made assumptions on the satisfaction of its DTC eligibility requirements that, although considered reasonable by the Company at the time of preparation, may prove to be incorrect.
About Columbia Care Inc.
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 19 jurisdictions (1,2,3) in the US and the EU. Columbia Care has completed more than 1.6 million sales transactions since inception and working in collaboration with renowned and innovative teaching hospitals and medical centers globally, continues to be a patient-centered health and wellness company setting the standard for compassion, professionalism, quality, care and innovation in the rapidly expanding cannabis industry. For more information on Columbia Care, please visit www.col-care.com.
Includes West Virginia industrial hemp cultivation license
Includes Colorado, subject to completion of the acquisition of The Green Solution
Missouri subject to the successful completion of a management services agreement through which the company intends to provide consultative services